Kathy Ordonez - 03 Jun 2026 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Reporting relationship: Director
Issuer ticker: PACB
Reported as of: 03 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2026, 17:20:51 UTC
Prior SEC filing: 06 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Brett Atkins, Attorney-in-fact

Key filing fact

Kathy Ordonez filed Form 4 for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) on 04 Jun 2026.

Key facts

This page summarizes Kathy Ordonez's Form 4 filing for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Jun 2026, 17:20.

Change

Previous filing in this sequence was filed on 06 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001222643 Primary reporting owner

ORDONEZ KATHY

Relationship: Director
Address: PACIFIC BIOSCIENCES OF CALIFORNIA, INC., 1305 O'BRIEN DRIVE, MENLO PARK
Signature: /s/ Brett Atkins, Attorney-in-fact
Signature date: 04 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PACB transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +223,492
Change %
Price: $0.000000^*
Shares after: 223,492
Date: 03 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 223,492
Exercise price: $1.58
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.